Alzheimer's disease and insulin resistance: translating basic science into clinical applications - Wikidata - awgldk - TriplyDB

Alzheimer's disease and insulin resistance: translating basic science into clinical applications

Alzheimer's disease and insulin resistance: translating basic science into clinical applications

http://www.wikidata.org/entity/Q26996487

about

Intranasal insulin as a treatment for Alzheimer's disease: a review of basic research and clinical evidence Brain Insulin Resistance at the Crossroads of Metabolic and Cognitive Disorders in Humans The Rationale for Insulin Therapy in Alzheimer's Disease The association between PGC-1α and Alzheimer's disease Current Research Therapeutic Strategies for Alzheimer's Disease Treatment Metabolic Risk Factors of Sporadic Alzheimer's Disease: Implications in the Pathology, Pathogenesis and Treatment At the interface of sensory and motor dysfunctions and Alzheimer's disease.Elevated risk of type 2 diabetes for development of Alzheimer disease: a key role for oxidative stress in brain Brain insulin resistance in Alzheimer's disease and its potential treatment with GLP-1 analogs Aberrant insulin signaling in Alzheimer's disease: current knowledge The brain response to peripheral insulin declines with age: a contribution of the blood-brain barrier?Lipid microdomain modification sustains neuronal viability in models of Alzheimer's disease Chronic adiponectin deficiency leads to Alzheimer's disease-like cognitive impairments and pathologies through AMPK inactivation and cerebral insulin resistance in aged mice.The Use of Neuroimaging to Assess Associations Among Diet, Nutrients, Metabolic Syndrome, and Alzheimer's Disease.Aerobic exercise improves quality of life, psychological well-being and systemic inflammation in subjects with Alzheimer's disease.The nature, significance, and glucagon-like peptide-1 analog treatment of brain insulin resistance in Alzheimer's disease.Overexpression of matrix metalloproteinase-9 (MMP-9) rescues insulin-mediated impairment in the 5XFAD model of Alzheimer's disease Intranasal insulin prevents anesthesia-induced hyperphosphorylation of tau in 3xTg-AD mice Effects of treadmill exercise on brain insulin signaling and β-amyloid in intracerebroventricular streptozotocin induced-memory impairment in rats.Continuation of exercise is necessary to inhibit high fat diet-induced β-amyloid deposition and memory deficit in amyloid precursor protein transgenic mice Alzheimer-associated Aβ oligomers impact the central nervous system to induce peripheral metabolic deregulation.Insulin improves memory and reduces chronic neuroinflammation in the hippocampus of young but not aged brains Insulin action in the human brain: evidence from neuroimaging studies.Soluble amyloid-β oligomers as synaptotoxins leading to cognitive impairment in Alzheimer's disease Increased Risk of Dementia in Patients With Erectile Dysfunction: A Population-Based, Propensity Score-Matched, Longitudinal Follow-Up Study.PPG neurons of the lower brain stem and their role in brain GLP-1 receptor activation.Fasting and Systemic Insulin Signaling Regulate Phosphorylation of Brain Proteins That Modulate Cell Morphology and Link to Neurological Disorders.Stop signs in hippocampal insulin signaling: the role of insulin resistance in structural, functional and behavioral deficits.Central Nervous Insulin Signaling in Sleep-Associated Memory Formation and Neuroendocrine Regulation.Brain Insulin Signaling Is Increased in Insulin-Resistant States and Decreases in FOXOs and PGC-1α and Increases in Aβ1-40/42 and Phospho-Tau May Abet Alzheimer Development.Cognitive enhancing treatment with a PPARγ agonist normalizes dentate granule cell presynaptic function in Tg2576 APP mice.Impaired glycemia increases disease progression in mild cognitive impairment.Dietary restriction in cerebral bioenergetics and redox state Protein Tyrosine Phosphatase 1B (PTP1B): A Potential Target for Alzheimer's Therapy?New insights into the role of glycogen synthase kinase-3 in Alzheimer's disease.Insulin dysfunction and Tau pathology.Fermenting soybeans with Bacillus licheniformis potentiates their capacity to improve cognitive function and glucose homeostaisis in diabetic rats with experimental Alzheimer's type dementia.Activation of mTOR: a culprit of Alzheimer's disease?Brain metabolic stress and neuroinflammation at the basis of cognitive impairment in Alzheimer's disease Tau deletion promotes brain insulin resistance

P2860

Q24601034-2B44E5DA-5298-434B-914B-7EAE53D150C1 Q26739671-F5DC7585-D634-43CC-BABE-2E16F9751433 Q26744834-CB8A13E0-FEDF-41C4-96EE-9F5BBD60DB6B Q26751165-10F29E70-B954-4800-BEEF-9DD6337D5BD4 Q26765530-116073E7-73E7-48D4-AFCD-2CB08A0C4106 Q26799893-041A3D47-E6A4-4A7B-B278-27ADBBA078D7 Q27000410-54B6E18A-AABD-48E0-A2F0-84D719501A47 Q27003253-989D82D3-16EF-45A5-B076-0CAC8F90FEBC Q27012801-BDBF4BDA-2C7A-43B1-9305-904D5007DE69 Q27024222-1650C136-3393-4283-AA5C-57F53E7CB10D Q27307127-6BECF9F4-4B0C-4257-B399-EF501B46C08A Q28278644-C4E1BD3A-6F99-44A0-963C-1CB75F2560A7 Q30829817-6C6118D5-A793-4673-84E5-209F45CC54C8 Q30996713-5173662B-ADA2-4FF0-B61F-D15C10894371 Q33584348-844C6ED9-B466-4E5D-A6B1-C848974F4259 Q33600053-EF793B14-5C78-41D4-9E83-DA770010893C Q33677609-12324E86-64B3-4892-BAB3-0F37B7472830 Q33687674-D9FC0872-4BFF-4369-91D3-E1A51060BD34 Q34563467-CB48F5E4-BE3D-4CD2-BDB0-BC8D34FCCDD7 Q34984057-09474F4A-D30D-4054-96C4-10F7E1E6ED8A Q35084406-0D3DC4AE-E293-436A-A05C-23A4FFB3935D Q35344466-75E17CCF-5222-4B34-90A5-DD6E28C4CE90 Q35543875-5D74AACE-15F9-44CA-A926-70FDE1BF7A41 Q35643397-D8897F57-FAB6-4CCA-8EC3-B6AAD14323A7 Q36194578-D3A4A0C7-E81F-4AA5-9A5E-6A55265CDF91 Q36339320-EE98FCF5-509E-4A88-9ED0-1447D0C4B96C Q36444140-717C6A15-20B8-4016-85EB-E03195B1DFDA Q36651084-AD55A953-7DB1-4B8A-92DF-D8FA2A4F4974 Q36799013-76B4A3AD-8E30-40AF-938D-B415C4239BA4 Q37025645-C54FB2AD-353E-4AE9-B76B-95D6BD9A06F4 Q37479405-F0A1C656-2002-4364-86CA-6D5D34149E1C Q37489320-D37B396A-76DB-4ABC-B8EF-53666394C772 Q37587834-32A22F57-E769-4232-9002-61F11BAECC4D Q37614594-52DC9BCB-174B-4BCD-B20E-A03D6B394CDB Q38149943-242E2F2D-7CC1-4089-81B1-83803ABF91A1 Q38191590-63AF2FEA-22D7-4F9B-B6AA-69963761D151 Q38439685-7B68AB8C-DE88-462B-92DC-0FD245D80C0E Q38443497-31AACFE5-4C73-4F85-A49F-72CE0E31AFE1 Q38515312-6F6B2418-C626-4D2A-8700-17FA666F8D39 Q38708062-A1EC1D24-F762-406F-BD69-AA7669ED342F

P2860

Alzheimer's disease and insulin resistance: translating basic science into clinical applications

http://www.wikidata.org/entity/Q26996487

description

2013 nî lūn-bûn

@nan

2013 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Alzheimer's disease and insuli ...... nce into clinical applications

@ast

Alzheimer's disease and insuli ...... nce into clinical applications

@en

Alzheimer's disease and insuli ...... nce into clinical applications

@nl

type

label

Alzheimer's disease and insuli ...... nce into clinical applications

@ast

Alzheimer's disease and insuli ...... nce into clinical applications

@en

Alzheimer's disease and insuli ...... nce into clinical applications

@nl

prefLabel

Alzheimer's disease and insuli ...... nce into clinical applications

@ast

Alzheimer's disease and insuli ...... nce into clinical applications

@en

Alzheimer's disease and insuli ...... nce into clinical applications

@nl

P1433

Q26996487-04BE780E-9502-48BF-A514-A72A1376A208

P1476

Q26996487-11ED3718-7C55-408A-BB1A-06E658A6868A

P2093

Q26996487-094D4B6A-64A7-40DE-8585-8193F2C8C952

P2860

Q26996487-0296649D-74E8-4C99-88A5-B0CC54613D21

Q26996487-03B1D72F-E0C3-4147-B687-37FE5A7646D7

Q26996487-04781D72-ED8C-4EEE-89DA-C190F13672F6

Q26996487-04B2A36E-51C3-4AF3-A5B4-5264BCE230CD

Q26996487-0526DB21-F61D-4F5A-A86B-8D1E59C00178

Q26996487-06563D4C-D8CD-4C3F-A55C-D29E03BDFFDD

Q26996487-06F830D0-493C-4F9A-8FB7-CE139B4D27E0

Q26996487-071E45A4-0593-4D68-88E7-12282F903CC1

Q26996487-09C5E457-F3E6-4B92-8D5A-68A68E366CB9

Q26996487-0ACD732C-09F2-4927-86A2-CD4D55D3DE5B

P304

Q26996487-6D08B84C-C7B2-4D7F-8488-7F3FC9EE518C

P31

Q26996487-02681B93-3B5D-4BB3-B45D-D57A7B95011A

P3181

Q26996487-87E6EE07-EEC2-49B8-B77B-D3314B088A89

P356

Q26996487-7D92F6A8-66CB-4203-9C87-31AFE7EEED61

P407

Q26996487-B57F5A10-3E85-4ABD-8CB1-F1AD4874D57F

P433

Q26996487-AA27FA2E-D08A-45FF-82D5-3C7F00C9681A

P478

Q26996487-9EA96B06-8020-4E14-AA1D-2131846A6A49

P577

Q26996487-C695C224-F985-4A99-BFBC-01471F86557A

P5875

Q26996487-FECC794F-1F13-4C75-9774-C15DFE7561C2

P698

Q26996487-CDB4CA08-468D-4608-9692-442010B8B716

P921

Q26996487-57854CF7-D9B1-410D-8D09-F45C9E29C0DE

Q26996487-E3AC6454-B011-4946-8F96-38A9DB3F737A

P932

Q26996487-FC28C790-C74E-423D-8F60-B5C8BEA897DD

P3181

P356

P1433

Journal of Clinical Investigation

P1476

Alzheimer's disease and insuli ...... nce into clinical applications

@en

P2093

Fernanda G. De Felice

http://www.w3.org/2001/XMLSchema#string

P2860

Intranasal delivery bypasses the blood-brain barrier to target therapeutic agents to the central nervous system and treat neurodegenerative disease

A Oligomer-Induced Aberrations in Synapse Composition, Shape, and Density Provide a Molecular Basis for Loss of Connectivity in Alzheimer's Disease

Amyloid plaque core protein in Alzheimer disease and Down syndrome

Intranasal insulin enhances postprandial thermogenesis and lowers postprandial serum insulin levels in healthy men

Endoplasmic reticulum stress and the inflammatory basis of metabolic disease

Amyloid-beta dynamics are regulated by orexin and the sleep-wake cycle

Pancreatic Extracts in the Treatment of Diabetes Mellitus

Tumor necrosis factor-induced cerebral insulin resistance in Alzheimer's disease links numerous treatment rationales

The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics

Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid beta-peptide

P304

531-9

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

3481081

http://www.w3.org/2001/XMLSchema#string

P356

10.1172/JCI64595

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

123

http://www.w3.org/2001/XMLSchema#string

P577

2013-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

236041928

http://www.w3.org/2001/XMLSchema#string

P698

23485579

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

P932

3561831

http://www.w3.org/2001/XMLSchema#string